Topical application of activity-based probes for visualization of brain tumor tissue

Jennifer L Cutter1, Nathan T Cohen, Jing Wang

  • 1Department of Radiology, National Foundation for Cancer Research Center for Molecular Imaging at Case Western Reserve University, Cleveland, Ohio, United States of America.

Plos One
|March 20, 2012
PubMed

Insights

This study introduces a new topical method for optical imaging probes to quickly identify tumor margins during surgery. This technique rapidly differentiates tumor from healthy tissue, aiding surgical precision.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Medical Imaging

Background:

  • Systemic delivery of optical imaging probes is established for tumor imaging in preclinical cancer models.
  • Current methods face limitations in rapid, precise tumor margin delineation during surgical procedures.

Purpose of the Study:

  • To develop and validate an innovative method for topical application of optical imaging probes for real-time tumor and margin visualization during surgery.
  • To assess the speed and specificity of topical probe activation compared to systemic delivery.

Main Methods:

  • Optical imaging probes were topically applied to tumors and surrounding tissues in preclinical models.
  • Rapid differentiation between tumor and normal tissue was assessed post-application.
  • Probe activation kinetics and localization (e.g., peri-tumor spaces) were analyzed.

Main Results:

  • Topical application of optical imaging probes rapidly differentiated between tumor and normal tissues.
  • Robust probe activation was detected as early as 5 minutes post-application.
  • Labeling was predominantly observed in peri-tumor spaces, highlighting tumor margins and potential infiltrating cells.

Conclusions:

  • Topical application of optical imaging probes offers a rapid and effective method for intraoperative visualization of tumors and their margins.
  • This technique has significant potential for improving surgical tumor excision and can be applied to tumors with differential cysteine cathepsin activity.

Related Concept Videos